ALL-C-2137

What is breast cancer?

Breast cancer is a malignant tumor that has developed from cells that continue to uncontrollably divide. According to the National Cancer Institute, it is the second most common cancer in women after skin cancer. Breast cancer can be diagnosed in different parts of the breast – the lobules, ducts, and connective tissue. If detected late, the cancer cells can metastasize and spread to other parts of the body.

Mode of Action

ALL-C-2137 targets human epidermal growth factor receptor 2 (HER2), a key protein in the development of certain types of aggressive breast cancer. Over-expression of HER2 is present in ~15-30% of breast cancers, and HER2 antibodies have been shown as an effective cancer treatment and a method to halt tumor proliferation in this patient population.

Back to list -->